বিকল্প অনুসন্ধান করুন:
justification » purification (অনুসন্ধান সম্প্রসারণ করুন), certification (অনুসন্ধান সম্প্রসারণ করুন)
notification » notifications (অনুসন্ধান সম্প্রসারণ করুন), certification (অনুসন্ধান সম্প্রসারণ করুন), verification (অনুসন্ধান সম্প্রসারণ করুন)
justification » purification (অনুসন্ধান সম্প্রসারণ করুন), certification (অনুসন্ধান সম্প্রসারণ করুন)
notification » notifications (অনুসন্ধান সম্প্রসারণ করুন), certification (অনুসন্ধান সম্প্রসারণ করুন), verification (অনুসন্ধান সম্প্রসারণ করুন)
-
61
Functional impact of PG modifications on colony opacity of <i>S. pneumoniae.</i>
প্রকাশিত 2025“…<p><b>(A)</b> Illustrative depiction of the two post-synthetic PG modifications. M, <i>N</i>-acetylmuramic acid (NAM). …”
-
62
Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles
প্রকাশিত 2025“…Finally, different chemical modifications introduced to the strands can be used to fine-tune the mechanical properties of the NANPs.…”
-
63
Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles
প্রকাশিত 2025“…Finally, different chemical modifications introduced to the strands can be used to fine-tune the mechanical properties of the NANPs.…”
-
64
Linker Modification Enables Control of Key Functional Group Orientation in Macrocycles
প্রকাশিত 2025বিষয়গুলি: -
65
Molecular masses of the fractions obtained as a result of lysozyme modification with pepsin.
প্রকাশিত 2025বিষয়গুলি: -
66
Linker Modification Enables Control of Key Functional Group Orientation in Macrocycles
প্রকাশিত 2025বিষয়গুলি: -
67
Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications
প্রকাশিত 2025“…Hydroxamic acid (HA)-based HDAC inhibitors often suffer from poor pharmacokinetic (PK) profiles, limiting their in vivo applications. Cap group modification offers a promising strategy to address these challenges. …”
-
68
Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications
প্রকাশিত 2025“…Hydroxamic acid (HA)-based HDAC inhibitors often suffer from poor pharmacokinetic (PK) profiles, limiting their in vivo applications. Cap group modification offers a promising strategy to address these challenges. …”
-
69
Research Progress on Histone Lactylation Modification in Ischemic Stroke: Mechanisms and Therapeutic Potential
প্রকাশিত 2025বিষয়গুলি: “…Histone lactylation modification…”
-
70
<b>Lossless Altered Histone Modification Analysis System (LAHMAS)</b>m
প্রকাশিত 2025“…The resultant Lossless Altered Histone Modification Analysis System (LAHMAS) employs a PDMS-silane treated glass surface immersed in silicone oil to facilitate lossless liquid handling and prevent sample evaporation. …”
-
71
Modification map illustrating the three-point force system for correcting pronation of the foot.
প্রকাশিত 2025বিষয়গুলি: -
72
Summary of Substituted Cysteine Modification and Anesthetic Protection Studies in α1 Subunits.
প্রকাশিত 2025বিষয়গুলি: “…substituted cysteine modification…”
-
73
-
74
Summary of Substituted Cysteine Modification and Anesthetic Protection Studies in β3 Subunits.
প্রকাশিত 2025বিষয়গুলি: “…substituted cysteine modification…”
-
75
-
76
Characteristics of the interventions: tailoring, modification, how well (planned) and how well (actual).
প্রকাশিত 2025“…<p>Characteristics of the interventions: tailoring, modification, how well (planned) and how well (actual).…”
-
77
-
78
-
79
-
80
Impact of RNA modification gene deletions on fitness during growth in sub-MIC tobramycin.
প্রকাশিত 2025বিষয়গুলি: